I'd say that I'm substantially more fit than last July. My weight has plateaued for four or five months now. This doesn't mean that I'm not still seeing the effects of the GLP-1 medicine. My bathroom scales attempt to show body composition and not simply is my BMI lower, but also are the readings of visceral fat. Because I'm supplementing, my protein levels are normal and I have increased total muscle mass.
I had my A1c tested back in April and I was happy seeing a 5.8 down from an all-time high of 6.3. I'm fairly sure I'm already in the normal range because my periodic glucose tests are now standard. So on that front, things are peachy already!
There was a belt I discovered in a dresser drawer that has no holes where they'd be needed now. I did donate all my size 38" waist pants and shorts to a thrift store and moved to 36". Most of them no longer feel snug and I am assuming that by next summer, I'll be able to downsize another couple of inches.
So, it all feels like sort of a slow moving miracle. And there's even better news in Canada. It's not that I already pay less than a third of the prices charged in the US. Novo Nordisk, the maker of Ozempic, neglected to file some important paperwork a few years ago protecting their exclusive patent rights. So, beginning in January 2026, semaglutide will go generic here and a few companies have signaled their intent to provide generic versions. That means the drug will probably drop to around $US50 or 60/month. And many more people will be able to benefit from it sooner rather than later.